Posted on June 24, 2014 by Sitemaster
A new article has explored further previously reported observations that prostate cancer appears to occur with lower incidence in men already diagnosed as positive for human immunodeficiency virus (HIV) than in their HIV-negative, “normal” peers. … READ MORE …
Filed under: Diagnosis, Risk | Tagged: Diagnosis, HIV, risk | 6 Comments »
Posted on July 3, 2012 by Sitemaster
It is definitely news that may be of considerable health relevance to many, many men, so …
The U.S. Food and Drug Administration (FDA) has today approved the OraQuick In-Home HIV Test, which therefore becomes the very first over-the-counter test for HIV infection that allows patients to get their own HIV results immediately, without any need to go to a doctor for the test.
Filed under: Uncategorized | Tagged: HIV, home, text | 2 Comments »
Posted on October 21, 2010 by Sitemaster
A report from the University of California San Diego says that robot-assisted laparoscopic prostatectomy (RALP) appears to be a safe and effective treatment for localized prostate cancer in men who are HIV-positive but are taking highly active antiretroviral therapy (HAART) and have undetectable viral loads (< 50). … READ MORE …
Filed under: Management, Treatment | Tagged: HIV, RALP, robot-assisted laparoscopic prostatectomy | Leave a comment »
Posted on March 18, 2009 by Sitemaster
Today we cover reports on:
- The incidence of prostate cancer among older HIV-positive men
- ARTS and the potential of dutasteride in treatment of patients with biochemical recurrence
- PET scans and their use in detection of biochemical recurrence
- Chemotherapy in treatment of prostate cancer … READ MORE …
Filed under: Diagnosis, Drugs in development, Management, Risk, Treatment, Uncategorized | Tagged: ARTS, chemotherapy, dutasteride, HIV, incidence, PET scan | Leave a comment »
Posted on September 4, 2008 by Sitemaster
Over the past 20 years, despite the fact that we have failed to develop any form of effective vaccine or other preventive form of treatment for human immunodeficiency virus (HIV), we have become pretty good at managing this disease with a variety of highly selective antiretroviral drugs. What this means is that men who, at an earlier time, would have died from progressive disease, are now living with their disease quite long enough to be at risk for prostate cancer. (The same is presumably true for women and breast cancer.) … READ MORE …
Filed under: Diagnosis, Management, Treatment | Tagged: cancer, HIV, prostate, screening, Treatment | Leave a comment »